{"entity":{"type":"insider","cik":"0001283084","url":"/insider/0001283084","json_url":"/insider/0001283084.json","name":"HARIBHAKTI KAMLESH","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2004-04-05","last":"2005-03-11","span_basis":"filed_date"},"name_variants":[{"name":"HARIBHAKTI KAMLESH","source":"filing","n_filings":5,"first_seen":"2004-04-05","last_seen":"2005-03-11"}],"transactions":[{"id":1616799,"accession":"0001072613-05-000656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001072613-05-000656","line_url":"/filing/0001072613-05-000656#line-1","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":227500.0,"total_display":"227,500.00","total_whole":"227,500","shares_owned_after":47842.0,"shares_owned_after_display":"47,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-11","scope":"insider"},{"id":325781,"accession":"0001072613-04-002276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001072613-04-002276","line_url":"/filing/0001072613-04-002276#line-2","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":21.63,"price_display":"21.63","price_state":"stated","total_value":86520.0,"total_display":"86,520.00","total_whole":"86,520","shares_owned_after":1667.0,"shares_owned_after_display":"1,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-01","filed_date":"2004-12-03","scope":"insider"},{"id":443799,"accession":"0001072613-04-001645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001072613-04-001645","line_url":"/filing/0001072613-04-001645#line-2","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":21.73,"price_display":"21.73","price_state":"stated","total_value":86920.0,"total_display":"86,920.00","total_whole":"86,920","shares_owned_after":1667.0,"shares_owned_after_display":"1,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-01","filed_date":"2004-09-03","scope":"insider"},{"id":325761,"accession":"0001072613-04-001128","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001072613-04-001128","line_url":"/filing/0001072613-04-001128#line-3","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4088.0,"shares_display":"4,088","price_per_share":18.4,"price_display":"18.40","price_state":"stated","total_value":75219.2,"total_display":"75,219.20","total_whole":"75,219","shares_owned_after":1667.0,"shares_owned_after_display":"1,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-03","scope":"insider"},{"id":325760,"accession":"0001072613-04-001128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001072613-04-001128","line_url":"/filing/0001072613-04-001128#line-2","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5912.0,"shares_display":"5,912","price_per_share":18.42,"price_display":"18.42","price_state":"stated","total_value":108899.04,"total_display":"108,899.04","total_whole":"108,899","shares_owned_after":5755.0,"shares_owned_after_display":"5,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-01","filed_date":"2004-06-03","scope":"insider"},{"id":642250,"accession":"0001072613-04-000750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001072613-04-000750","line_url":"/filing/0001072613-04-000750#line-2","is_derivative":false,"issuer_cik":"0000857171","issuer_name":"ABLE LABORATORIES INC","issuer_ticker":"ABRX","issuer_name_source":null,"issuer_url":"/issuer/0000857171","owner_cik":"0001283084","owner_name":"HARIBHAKTI KAMLESH","owner_display_name":"HARIBHAKTI KAMLESH","owner_url":"/insider/0001283084","role":"Officer (Director - Product Development)","role_mark":"O","role_mark_label":"Officer (Director - Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director - Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.38,"price_display":"19.38","price_state":"stated","total_value":193800.0,"total_display":"193,800.00","total_whole":"193,800","shares_owned_after":1667.0,"shares_owned_after_display":"1,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-04-01","filed_date":"2004-04-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000857171","name":"ABLE LABORATORIES INC","url":"/issuer/0000857171","role":"Officer (Director - Product Development)","n_filings":5,"first_seen":"2004-04-05","last_seen":"2005-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283084","retrieved_at":"2026-08-26T12:43:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}